EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹132 Cr | ₹404 Cr | ₹310 Cr | ₹222 Cr | ₹332 Cr |
What is the latest Capital Work in Progress ratio of EMCURE PHARMACEUTICALS ?
Year | Capital Work in Progress |
---|---|
Mar2024 | ₹132 Cr |
Mar2023 | ₹404 Cr |
Mar2022 | ₹310 Cr |
Mar2021 | ₹222 Cr |
Mar2020 | ₹332 Cr |
How is Capital Work in Progress of EMCURE PHARMACEUTICALS Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2024 | ₹132 Cr | -67.20 | |
Mar2023 | ₹404 Cr | 30.25 | |
Mar2022 | ₹310 Cr | 39.81 | |
Mar2021 | ₹222 Cr | -33.24 | |
Mar2020 | ₹332 Cr | - |
Compare Capital Work in Progress of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹25,681.0 Cr | 9% | -0.6% | -4.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 9% |
-0.6% |
-4.6% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses